By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, Inc. (NASDAQ:VKTX) announced a significant milestone in the development of ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
Wasatch Core Growth Fund’s underperformance was largely due to one factor—lack of exposure to biotechnology stocks. Read more here.
Maarten Jacobs oversaw the project’s development for its owner, the nonprofit Allyn Family Foundation. Jacobs, now the ...
In certain cases, regulators will now be open to clearing therapies based on their ability to eliminate tumor cells, a change ...
The FDA granted orphan drug designation to zavabresib, an investigational therapy for the treatment of myelofibrosis, a rare ...
We asked certified financial planners, investment advisers and other money experts their thoughts on stock choices this year ...
Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results